Wednesday, June 01, 2011 6:30:02 PM
I think you and I are on the same page now.
Thanks also to Mojo and Djohn. I knew you guys are better computer researchers than I am and together we may yet get to the bottom of this. It is very interesting and the more one pulls on this thread the more it unravels and the more interesting it becomes IMO.
The real question IMO is in understanding the IST "equation" which PPHM for whatever reason does not want to fully explain. It is pretty self evident what the benefits of ISTs are to PPHM but, what are the real benefits of ISTs to the institutions that are conducting the trials??? After all PPHM controls any potential positive outcomes by virtue of controlling Bavituximab supply and manufacture and by patents that are "substantial" not "design" and are therefore much more difficult to circumnavigate. (BTW the more you understand the PPHM position here the more you understand the enormity of their accomplishment and the less likely you will be to refer to them as idiots IMO)
If in IST #4 PPHM and UC/Irvine are splitting the funding, who or what entity is really behind the UC/Irvine half of this?? If you recall this board had an inkling about IST #4 weeks before it was officially announced. I "suspect" there was a bit of bargaining before this became official. It could be "altruistic in the same manner that the "Chao" family funded this whole facility at UC/ Irvine but I suspect there is more going on here. If one of you guys can figure this out you get the first annual RRdog research award (which BTW carries no prize whatsoever).
And then there are IST #s 1-3. Who is funding those since PPHM is less "collaborative" in these and what is the motivation??
My "conjecture" is that PPHM is much deeper in discussions with large biotech entities than we know and that is why they are very understated in their discussion of the IST equation. Of course, I can't prove this but one of you guys may come up with something.
Regards,
RRdog
Recent CDMO News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 08:45:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 11:40:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:37:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:22:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:21:22 AM
- Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference • GlobeNewswire Inc. • 09/12/2024 08:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/09/2024 08:43:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:19:30 PM
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 • GlobeNewswire Inc. • 09/09/2024 08:05:31 PM
- U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns • IH Market News • 09/09/2024 10:09:14 AM
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 • GlobeNewswire Inc. • 09/03/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 08:30:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/28/2024 08:34:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/28/2024 08:32:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2024 08:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM